UWA world-first study on diabetes patients

Thursday, October 5, 2017 1:34 pm
Reading Time: 1 minute

The University of Western Australia professor of cardiology Carl Schultz is seeking volunteers to take part in a world-first study on the effects of Vitamin K on diabetes patients.

The study is called VikCoVac and is investigating “the effects of Vitamin K and the Colchicine on vascular calcification activity”.

It is:

  • taking place at Royal Perth Hospital in partnership with The University of Western Australia;
  • looking for anyone over the age of 40; and
  • looking for those who are diagnosed diabetes and who have never had a bypass surgery or a stent.

There is no cost the participants.

Podcast: UWA professor of cardiology Carl Schultz on world-first study and appealing for diagnosed diabetes patients

For more information on this study and find out how you can participate:

Visit: VikCoVac Study

Call: 08 9224 3181

By Altus Vernooy | Volunteer Mornings producer

Skip to toolbar